Table 3.
Model | F | R2 | a | b | c | c’ | % | IND | 95% CI | |
---|---|---|---|---|---|---|---|---|---|---|
LL | UL | |||||||||
A | 50.61*** | 0.12 | −5.18*** | 0.12*** | −1.78*** | −1.18*** | 26 | −0.60 | −0.84 | −0.39 |
B | 41.28*** | 0.10 | 10.72*** | 0.16*** | 1.76*** | 0.41 | 49 | 1.35 | 0.96 | 1.77 |
C | 41.85*** | 0.11 | 6.50*** | 0.13*** | 1.44** | 0.60 | 37 | 0.84 | 0.53 | 1.19 |
D | 70.04*** | 0.09 | 6.49*** | 0.11*** | 3.30*** | 2.58*** | 18 | 0.72 | 0.45 | 1.03 |
E | 41.11*** | 0.10 | 8.95*** | 0.13*** | 1.48*** | 0.33 | 44 | 1.15 | 0.83 | 1.50 |
Notes: ** p < 0.01; *** p < 0.001.
Abbreviations: A, NEU-EI-GRA; B, EXT-EI-GRA; C, OPE-EI-GRA; D, AGR-EI-GRA; E, CON-EI-GRA; %, mediation proportion; IND, indirect; LL, lower limit; UL, upper limit.